An overview of hereditary pancreatitis

Digestive and Liver Disease

Volumn 44, Issue 1, 2012, Pages 8-15

  Rebours, Vinciane ^a   Lévy, Philippe ^a   Ruszniewski, Philippe ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Cationic trypsinogen mutation; Chronic pancreatitis; Diabetes mellitus; Epidemiology; Exocrine pancreatic failure; Hereditary pancreatitis; Pancreatic adenocarcinoma; PRSS1

Indexed keywords

ALPHA TOCOPHEROL; AMLODIPINE; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; METHIONINE; OCTREOTIDE; PANCREAS ENZYME; PROTEIN; PROTEIN PRSS1; SELENIUM; SOMATOSTATIN; TRACE ELEMENT; TRYPSINOGEN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ALCOHOL ABSTINENCE; AUTOSOMAL DOMINANT INHERITANCE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHROMOSOME 7; CHRONIC PANCREATITIS; CLINICAL FEATURE; DIABETES MELLITUS; ENDOCRINE DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME RELEASE; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INHERITANCE; METABOLISM; MORTALITY; ONSET AGE; OXIDATIVE STRESS; PANCREAS ADENOCARCINOMA; PANCREAS CALCIFICATION; PANCREAS FUNCTION; PANCREATITIS; PENETRANCE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING; STEATORRHEA; SURVIVAL; SYMPTOM; VISUAL ANALOG SCALE;

ADENOCARCINOMA; AGE FACTORS; EARLY DETECTION OF CANCER; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; RISK;

EID: 83855165766     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.08.003     Document Type: Review

References (69)

1. Comfort M.W., Steinberg A.G. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952, 21:54-63.
2. Le Bodic L., Schnee M., Georgelin T., et al. An exceptional genealogy for hereditary chronic pancreatitis. Dig Dis Sci 1996, 41:1504-1510.
3. Le Bodic L., Bignon J.D., Raguenes O., et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet 1996, 5:549-554.
4. Pandya A., Blanton S.H., Landa B., et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics 1996, 38:227-230.
5. Whitcomb D.C., Preston R.A., Aston C.E., et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996, 110:1975-1980.
6. Whitcomb D.C., Gorry M.C., Preston R.A., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141-145.
7. Ferec C., Raguenes O., Salomon R., et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999, 36:228-232.
8. Chen J.M., Mercier B., Ferec C. Strong evidence that the N21I substitution in the cationic trypsinogen gene causes disease in hereditary pancreatitis. Gut 1999, 45:916.
9. Chen J.M., Ferec C. Molecular basis of hereditary pancreatitis. Eur J Hum Genet 2000, 8:473-479.
10. Howes N., Greenhalf W., Rutherford S., et al. A new polymorphism for the RI22H mutation in hereditary pancreatitis. Gut 2001, 48:247-250.
11. Le Marechal C., Bretagne J.F., Raguenes O., et al. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1). Mol Genet Metab 2001, 74:342-344.
12. Teich N., Bauer N., Mossner J., et al. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002, 97:341-346.
13. Teich N., Le Marechal C., Kukor Z., et al. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 2004, 23:22-31.
14. Pfutzer R., Myers E., Applebaum-Shapiro S., et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 2002, 50:271-272.
15. Chen J.M., Ferec C. Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family. Mol Genet Metab 2000, 71:463-469.
16. Guy O., Lombardo D., Bartelt D.C., et al. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry 1978, 17:1669-1675.
17. Rinderknecht H., Renner I.G., Carmack C. Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas. Gut 1979, 20:886-891.
18. Rinderknecht H., Stace N.H., Renner I.G. Effects of chronic alcohol abuse on exocrine pancreatic secretion in man. Dig Dis Sci 1985, 30:65-71.
19. Rinderknecht H., Renner I.G., Abramson S.B., et al. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 1984, 86:681-692.
20. Sahin-Toth M., Toth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 2000, 278:286-289.
21. Sahin-Toth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 2000, 275:22750-22755.
22. Gorry M.C., Gabbaizedeh D., Furey W., et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997, 113:1063-1068.
23. Teich N., Mossner J., Keim V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat 1998, 12:39-43.
24. Keim V., Bauer N., Teich N., et al. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001, 111:622-626.
25. Witt H., Luck W., Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999, 117:7-10.
26. Chen J.M., Raguenes O., Ferec C., et al. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. Gastroenterology 1999, 117:1508-1509.
27. Chen J.M., Piepoli Bis A., Le Bodic L., et al. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet 2001, 59:189-193.
28. Grocock C.J., Rebours V., Delhaye M.N., et al. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families. Gut 2010, 59:357-363.
29. Kereszturi E., Szmola R., Kukor Z., et al. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat 2009, 30:575-582.
30. Nemoda Z., Sahin-Toth M. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem 2006, 281:11879-11886.
31. Kereszturi E., Sahin-Toth M. Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death. J Biol Chem 2009, 284:33392-33399.
32. Howes N., Lerch M.M., Greenhalf W., et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004, 2:252-261.
33. Rebours V., Boutron-Ruault M.C., Schnee M., et al. The natural history of hereditary pancreatitis: a national series. Gut 2009, 58:97-103.
34. Joergensen M.T., Brusgaard K., Cruger D.G., et al. Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a population-based cohort study in Denmark. Am J Gastroenterol 2010, 105:1876-1883.
35. Joergensen M., Brusgaard K., Cruger D.G., et al. Incidence, prevalence, etiology, and prognosis of first-time chronic pancreatitis in young patients: a nationwide cohort study. Dig Dis Sci 2010, 55:2988-2998.
36. Sibert J.R. Hereditary pancreatitis in England and Wales. J Med Genet 1978, 15:189-201.
37. Weiss F.U., Zenker M., Ekici A.B., et al. Local clustering of PRSS1 R122H mutations in hereditary pancreatitis patients from Northern Germany. Am J Gastroenterol 2008, 103:2585-2588.
38. de las Heras-Castano G., Castro-Senosiain B., Fontalba A., et al. Hereditary pancreatitis: clinical features and inheritance characteristics of the R122C mutation in the cationic trypsinogen gene (PRSS1) in six Spanish families. JOP 2009, 10:249-255.
39. Felderbauer P., Schnekenburger J., Lebert R., et al. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site. J Med Genet 2008, 45:507-512.
40. Tautermann G., Ruebsamen H., Beck M., et al. R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis. Digestion 2001, 64:226-232.
41. Pho-Iam T., Thongnoppakhun W., Yenchitsomanus P.T., et al. A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene. World J Gastroenterol 2005, 11:1634-1638.
42. Malka D., Hammel P., Maire F., et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002, 51:849-852.
43. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993, 328:1433-1437.
44. Lowenfels A.B., Maisonneuve P., DiMagno E.P., et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997, 89:442-446.
45. Rebours V., Boutron-Ruault M.C., Schnee M.F., et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008, 103:111-119.
46. Lowenfels A.B., Maisonneuve P., Whitcomb D.C., et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001, 286:169-170.
47. Ammann R.W., Akovbiantz A., Largiader F., et al. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984, 86:820-828.
48. Levy P., Milan C., Pignon J.P., et al. Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients. Gastroenterology 1989, 96:1165-1172.
49. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol 1994, 89:1467-1471.
50. Dancour A., Levy P., Milan C., et al. Natural history of non-alcoholic chronic pancreatitis. Study of 37 cases and comparison with 319 cases of alcoholic chronic pancreatitis. Gastroenterol Clin Biol 1993, 17:915-924.
51. Rebours V., Boutron-Ruault M.C., Jooste V., et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses. Am J Gastroenterol 2009, 104:2312-2317.
52. Volkholz H., Stolte M., Becker V. Epithelial dysplasias in chronic pancreatitis. Virchows Arch A Pathol Anat Histol 1982, 396:331-349.
53. Gerdes B., Ramaswamy A., Kersting M., et al. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer. Surgery 2001, 129:490-497.
54. Luttges J., Kloppel G. Precancerous conditions of pancreatic carcinoma. J Hepatobiliary Pancreat Surg 2000, 7:568-574.
55. Rebours V., Levy P., Mosnier J.F., et al. Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis. Clin Gastroenterol Hepatol 2010, 8:206-212.
56. Brune K., Abe T., Canto M., et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006, 30:1067-1076.
57. Brentnall T.A., Bronner M.P., Byrd D.R., et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999, 131:247-255.
58. Kimmey M.B., Bronner M.P., Byrd D.R., et al. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 2002, 56(4 Suppl.):S82-S86.
59. Crnogorac-Jurcevic T., Gangeswaran R., Bhakta V., et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005, 129:1454-1463.
60. Furuya N., Kawa S., Akamatsu T., et al. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997, 113:593-598.
61. Li Z.S., Wang W., Liao Z., et al. A long-term follow-up study on endoscopic management of children and adolescents with chronic pancreatitis. Am J Gastroenterol 2010, 105:1884-1892.
62. Dever J.B., Irani S., Brandabur J., et al. Outcomes of interventional ERCP in hereditary pancreatitis. J Clin Gastroenterol 2010, 44:46-51.
63. Moir C.R., Konzen K.M., Perrault J. Surgical therapy and long-term follow-up of childhood hereditary pancreatitis. J Pediatr Surg 1992, 27:282-286. discussion 6-7.
64. Brown A., Hughes M., Tenner S., et al. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol 1997, 92:2032-2035.
65. Uhl W., Anghelacopoulos S.E., Friess H., et al. The role of octreotide and somatostatin in acute and chronic pancreatitis. Digestion 1999, 60(Suppl. 2):23-31.
66. Malfertheiner P., Mayer D., Buchler M., et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995, 36:450-454.
67. Morinville V.D., Lowe M.E., Elinoff B.D., et al. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. Pancreas 2007, 35:308-312.
68. Mathew P., Wyllie R., Van Lente F., et al. Antioxidants in hereditary pancreatitis. Am J Gastroenterol 1996, 91:1558-1562.
69. Uomo G., Talamini G., Rabitti P.G. Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients. Dig Liver Dis 2001, 33:58-62.